Nucleoside Reverse-Transcriptase Inhibitor Resistance Mutations Predict Virological Failure in Human Immunodeficiency Virus-Positive Patients During Lamivudine Plus Dolutegravir Maintenance Therapy in Clinical Practice

The TANGO trial demonstrated the efficacy of lamivudine plus dolutegravir in virologically suppressed patients without previous virological failures (VFs). In this dataset from clinical practice investigating the impact of past nucleoside reverse-transcriptase inhibitor resistance on this strategy,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Open Forum Infect Dis
Autors principals: Borghetti, Alberto, Giacomelli, Andrea, Borghi, Vanni, Ciccullo, Arturo, Dusina, Alex, Fabbiani, Massimiliano, Rusconi, Stefano, Zazzi, Maurizio, Mussini, Cristina, Di Giambenedetto, Simona
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2021
Matèries:
Brief Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8314943/
https://ncbi.nlm.nih.gov/pubmed/34327247
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofab103
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars